Skip to main content
Top
Published in: Abdominal Radiology 6/2015

01-08-2015 | Pictorial Essay

Central element in liver masses, helpful, or pitfall?

Authors: C. Rousseau, M. Ronot, E. Sibileau, I. Boulay-Coletta, M. Lewin, V. Duchatelle, V. Vilgrain, M. Zins

Published in: Abdominal Radiology | Issue 6/2015

Login to get access

Abstract

A central element was first described in focal nodular hyperplasia (FNH) as a so-called “central scar,” and is normally associated with this entity. However, many other liver masses may present with a central element. Depending on its appearance, and the lesion itself, central elements can be essential, helpful, or confusing for diagnosis. Indeed, nodules that develop on liver vascular disorders, fibrolamellar hepatocellular carcinoma, large hemangioma, peripheral cholangiocarcinoma, or epithelioid hemangioenthelioma often present with a central element, thus increasing the level of diagnostic confidence when present. On the other hand, central elements are rare or atypical in liver metastases, hepatocellular adenoma, or hepatocellular carcinoma. In this setting, the presence of a central element can lead to a misdiagnosis. The description and details of the imaging features of these different central elements, especially on MRI, as well as a thorough evaluation of the entire lesion, can improve the diagnostic performance in these cases.
Literature
2.
go back to reference Shamsi K, De Schepper A, Degryse H, Deckers F (1993) Focal nodular hyperplasia of the liver: radiologic findings. Abdom Imaging 18:32–38PubMedCrossRef Shamsi K, De Schepper A, Degryse H, Deckers F (1993) Focal nodular hyperplasia of the liver: radiologic findings. Abdom Imaging 18:32–38PubMedCrossRef
3.
go back to reference Wang W, Chen LD, Lu MD, et al. (2013) Contrast-enhanced ultrasound features of histologically proven focal nodular hyperplasia: diagnostic performance compared with contrast-enhanced CT. Eur Radiol 23:2546–2554PubMedCrossRef Wang W, Chen LD, Lu MD, et al. (2013) Contrast-enhanced ultrasound features of histologically proven focal nodular hyperplasia: diagnostic performance compared with contrast-enhanced CT. Eur Radiol 23:2546–2554PubMedCrossRef
4.
go back to reference Ungermann L, Elias P, Zizka J, Ryska P, Klzo L (2007) Focal nodular hyperplasia: spoke-wheel arterial pattern and other signs on dynamic contrast-enhanced ultrasonography. Eur J Radiol 63:290–294PubMedCrossRef Ungermann L, Elias P, Zizka J, Ryska P, Klzo L (2007) Focal nodular hyperplasia: spoke-wheel arterial pattern and other signs on dynamic contrast-enhanced ultrasonography. Eur J Radiol 63:290–294PubMedCrossRef
5.
go back to reference Quaia E, Calliada F, Bertolotto M, et al. (2004) Characterization of focal liver lesions with contrast-specific US modes and a sulfur hexafluoride-filled microbubble contrast agent: diagnostic performance and confidence. Radiology 232:420–430PubMedCrossRef Quaia E, Calliada F, Bertolotto M, et al. (2004) Characterization of focal liver lesions with contrast-specific US modes and a sulfur hexafluoride-filled microbubble contrast agent: diagnostic performance and confidence. Radiology 232:420–430PubMedCrossRef
6.
go back to reference Mortele KJ, Praet M, Van Vlierberghe H, Kunnen M, Ros PR (2000) CT and MR imaging findings in focal nodular hyperplasia of the liver: radiologic–pathologic correlation. AJR Am J Roentgenol 175:687–692PubMedCrossRef Mortele KJ, Praet M, Van Vlierberghe H, Kunnen M, Ros PR (2000) CT and MR imaging findings in focal nodular hyperplasia of the liver: radiologic–pathologic correlation. AJR Am J Roentgenol 175:687–692PubMedCrossRef
7.
go back to reference Mortele KJ, Praet M, Van Vlierberghe H, et al. (2002) Focal nodular hyperplasia of the liver: detection and characterization with plain and dynamic-enhanced MRI. Abdom Imaging 27:700–707PubMedCrossRef Mortele KJ, Praet M, Van Vlierberghe H, et al. (2002) Focal nodular hyperplasia of the liver: detection and characterization with plain and dynamic-enhanced MRI. Abdom Imaging 27:700–707PubMedCrossRef
8.
go back to reference Kehagias D, Moulopoulos L, Antoniou A, et al. (2001) Focal nodular hyperplasia: imaging findings. Eur Radiol 11:202–212PubMedCrossRef Kehagias D, Moulopoulos L, Antoniou A, et al. (2001) Focal nodular hyperplasia: imaging findings. Eur Radiol 11:202–212PubMedCrossRef
9.
go back to reference Grieser C, Steffen IG, Seehofer D, et al. (2013) Histopathologically confirmed focal nodular hyperplasia of the liver: gadoxetic acid-enhanced MRI characteristics. Magn Reson Imaging 31:755–760PubMedCrossRef Grieser C, Steffen IG, Seehofer D, et al. (2013) Histopathologically confirmed focal nodular hyperplasia of the liver: gadoxetic acid-enhanced MRI characteristics. Magn Reson Imaging 31:755–760PubMedCrossRef
10.
go back to reference Vilgrain V, Flejou JF, Arrive L, et al. (1992) Focal nodular hyperplasia of the liver: MR imaging and pathologic correlation in 37 patients. Radiology 184:699–703PubMedCrossRef Vilgrain V, Flejou JF, Arrive L, et al. (1992) Focal nodular hyperplasia of the liver: MR imaging and pathologic correlation in 37 patients. Radiology 184:699–703PubMedCrossRef
11.
go back to reference Cherqui D, Rahmouni A, Charlotte F, et al. (1995) Management of focal nodular hyperplasia and hepatocellular adenoma in young women: a series of 41 patients with clinical, radiological, and pathological correlations. Hepatology 22:1674–1681PubMedCrossRef Cherqui D, Rahmouni A, Charlotte F, et al. (1995) Management of focal nodular hyperplasia and hepatocellular adenoma in young women: a series of 41 patients with clinical, radiological, and pathological correlations. Hepatology 22:1674–1681PubMedCrossRef
12.
go back to reference Bertin C, Egels S, Wagner M, et al. (2014) Contrast-enhanced ultrasound of focal nodular hyperplasia: a matter of size. Eur Radiol 24:2561–2571PubMedCrossRef Bertin C, Egels S, Wagner M, et al. (2014) Contrast-enhanced ultrasound of focal nodular hyperplasia: a matter of size. Eur Radiol 24:2561–2571PubMedCrossRef
13.
go back to reference Maetani Y, Itoh K, Egawa H, et al. (2002) Benign hepatic nodules in Budd–Chiari syndrome: radiologic–pathologic correlation with emphasis on the central scar. AJR Am J Roentgenol 178:869–875PubMedCrossRef Maetani Y, Itoh K, Egawa H, et al. (2002) Benign hepatic nodules in Budd–Chiari syndrome: radiologic–pathologic correlation with emphasis on the central scar. AJR Am J Roentgenol 178:869–875PubMedCrossRef
14.
go back to reference Vilgrain V, Lewin M, Vons C, et al. (1999) Hepatic nodules in Budd–Chiari syndrome: imaging features. Radiology 210:443–450PubMedCrossRef Vilgrain V, Lewin M, Vons C, et al. (1999) Hepatic nodules in Budd–Chiari syndrome: imaging features. Radiology 210:443–450PubMedCrossRef
15.
go back to reference Zhou H, Wolff M, Pauleit D, Fischer HP, Pfeifer U (2000) Multiple macroregenerative nodules in liver cirrhosis due to Budd–Chiari syndrome. Case reports and review of the literature. Hepatogastroenterology 47:522–527PubMed Zhou H, Wolff M, Pauleit D, Fischer HP, Pfeifer U (2000) Multiple macroregenerative nodules in liver cirrhosis due to Budd–Chiari syndrome. Case reports and review of the literature. Hepatogastroenterology 47:522–527PubMed
16.
go back to reference Kim T, Murakami T, Sugihara E, et al. (2004) Hepatic nodular lesions associated with abnormal development of the portal vein. AJR Am J Roentgenol 183:1333–1338PubMedCrossRef Kim T, Murakami T, Sugihara E, et al. (2004) Hepatic nodular lesions associated with abnormal development of the portal vein. AJR Am J Roentgenol 183:1333–1338PubMedCrossRef
17.
go back to reference Vilgrain V, Rautou PE, Paradis V, Ronot M (2014) Benign and malignant hepatocellular lesions in patients with vascular liver disease. Clin Liver Dis 3(6):122–125CrossRef Vilgrain V, Rautou PE, Paradis V, Ronot M (2014) Benign and malignant hepatocellular lesions in patients with vascular liver disease. Clin Liver Dis 3(6):122–125CrossRef
18.
go back to reference Ichikawa T, Federle MP, Grazioli L, et al. (1999) Fibrolamellar hepatocellular carcinoma: imaging and pathologic findings in 31 recent cases. Radiology 213:352–361PubMedCrossRef Ichikawa T, Federle MP, Grazioli L, et al. (1999) Fibrolamellar hepatocellular carcinoma: imaging and pathologic findings in 31 recent cases. Radiology 213:352–361PubMedCrossRef
19.
go back to reference Friedman AC, Lichtenstein JE, Goodman Z, et al. (1985) Fibrolamellar hepatocellular carcinoma. Radiology 157:583–587PubMedCrossRef Friedman AC, Lichtenstein JE, Goodman Z, et al. (1985) Fibrolamellar hepatocellular carcinoma. Radiology 157:583–587PubMedCrossRef
20.
go back to reference McLarney JK, Rucker PT, Bender GN, et al. (1999) Fibrolamellar carcinoma of the liver: radiologic–pathologic correlation. Radiographics 19:453–471PubMedCrossRef McLarney JK, Rucker PT, Bender GN, et al. (1999) Fibrolamellar carcinoma of the liver: radiologic–pathologic correlation. Radiographics 19:453–471PubMedCrossRef
21.
go back to reference Brandt DJ, Johnson CD, Stephens DH, Weiland LH (1988) Imaging of fibrolamellar hepatocellular carcinoma. AJR Am J Roentgenol 151:295–299PubMedCrossRef Brandt DJ, Johnson CD, Stephens DH, Weiland LH (1988) Imaging of fibrolamellar hepatocellular carcinoma. AJR Am J Roentgenol 151:295–299PubMedCrossRef
22.
go back to reference Blachar A, Federle MP, Ferris JV, et al. (2002) Radiologists’ performance in the diagnosis of liver tumors with central scars by using specific CT criteria. Radiology 223:532–539PubMedCrossRef Blachar A, Federle MP, Ferris JV, et al. (2002) Radiologists’ performance in the diagnosis of liver tumors with central scars by using specific CT criteria. Radiology 223:532–539PubMedCrossRef
23.
go back to reference Caseiro-Alves F, Zins M, Mahfouz AE, et al. (1996) Calcification in focal nodular hyperplasia: a new problem for differentiation from fibrolamellar hepatocellular carcinoma. Radiology 198:889–892PubMedCrossRef Caseiro-Alves F, Zins M, Mahfouz AE, et al. (1996) Calcification in focal nodular hyperplasia: a new problem for differentiation from fibrolamellar hepatocellular carcinoma. Radiology 198:889–892PubMedCrossRef
24.
go back to reference Bartolozzi C, Battaglia V, Bozzi E (2009) HCC diagnosis with liver-specific MRI–close to histopathology. Dig Dis 27:125–130PubMedCrossRef Bartolozzi C, Battaglia V, Bozzi E (2009) HCC diagnosis with liver-specific MRI–close to histopathology. Dig Dis 27:125–130PubMedCrossRef
25.
go back to reference Corrigan K, Semelka RC (1995) Dynamic contrast-enhanced MR imaging of fibrolamellar hepatocellular carcinoma. Abdom Imaging 20:122–125PubMedCrossRef Corrigan K, Semelka RC (1995) Dynamic contrast-enhanced MR imaging of fibrolamellar hepatocellular carcinoma. Abdom Imaging 20:122–125PubMedCrossRef
26.
go back to reference Honda H, Onitsuka H, Yasumori K, et al. (1993) Intrahepatic peripheral cholangiocarcinoma: two-phased dynamic incremental CT and pathologic correlation. J Comput Assist Tomogr 17:397–402PubMedCrossRef Honda H, Onitsuka H, Yasumori K, et al. (1993) Intrahepatic peripheral cholangiocarcinoma: two-phased dynamic incremental CT and pathologic correlation. J Comput Assist Tomogr 17:397–402PubMedCrossRef
27.
go back to reference Maetani Y, Itoh K, Watanabe C, et al. (2001) MR imaging of intrahepatic cholangiocarcinoma with pathologic correlation. AJR Am J Roentgenol 176:1499–1507PubMedCrossRef Maetani Y, Itoh K, Watanabe C, et al. (2001) MR imaging of intrahepatic cholangiocarcinoma with pathologic correlation. AJR Am J Roentgenol 176:1499–1507PubMedCrossRef
28.
go back to reference Ros PR, Buck JL, Goodman ZD, Ros AM, Olmsted WW (1988) Intrahepatic cholangiocarcinoma: radiologic–pathologic correlation. Radiology 167:689–693PubMedCrossRef Ros PR, Buck JL, Goodman ZD, Ros AM, Olmsted WW (1988) Intrahepatic cholangiocarcinoma: radiologic–pathologic correlation. Radiology 167:689–693PubMedCrossRef
29.
go back to reference Outwater E, Kaplan MM, Bankoff MS (1992) Lymphadenopathy in sclerosing cholangitis: pitfall in the diagnosis of malignant biliary obstruction. Gastrointest Radiol 17:157–160PubMedCrossRef Outwater E, Kaplan MM, Bankoff MS (1992) Lymphadenopathy in sclerosing cholangitis: pitfall in the diagnosis of malignant biliary obstruction. Gastrointest Radiol 17:157–160PubMedCrossRef
30.
go back to reference Soyer P, Bluemke DA, Vissuzaine C, et al. (1994) CT of hepatic tumors: prevalence and specificity of retraction of the adjacent liver capsule. AJR Am J Roentgenol 162:1119–1122PubMedCrossRef Soyer P, Bluemke DA, Vissuzaine C, et al. (1994) CT of hepatic tumors: prevalence and specificity of retraction of the adjacent liver capsule. AJR Am J Roentgenol 162:1119–1122PubMedCrossRef
31.
go back to reference Soyer P, Bluemke DA, Reichle R, et al. (1995) Imaging of intrahepatic cholangiocarcinoma: 1. Peripheral cholangiocarcinoma. AJR. Am J Roentgenol 165:1427–1431CrossRef Soyer P, Bluemke DA, Reichle R, et al. (1995) Imaging of intrahepatic cholangiocarcinoma: 1. Peripheral cholangiocarcinoma. AJR. Am J Roentgenol 165:1427–1431CrossRef
32.
33.
go back to reference Scatarige JC, Kenny JM, Fishman EK, Herlong FH, Siegelman SS (1987) CT of giant cavernous hemangioma. AJR Am J Roentgenol 149:83–85PubMedCrossRef Scatarige JC, Kenny JM, Fishman EK, Herlong FH, Siegelman SS (1987) CT of giant cavernous hemangioma. AJR Am J Roentgenol 149:83–85PubMedCrossRef
34.
go back to reference Choi BY, Nguyen MH (2005) The diagnosis and management of benign hepatic tumors. J Clin Gastroenterol 39:401–412PubMedCrossRef Choi BY, Nguyen MH (2005) The diagnosis and management of benign hepatic tumors. J Clin Gastroenterol 39:401–412PubMedCrossRef
35.
go back to reference Danet IM, Semelka RC, Braga L, Armao D, Woosley JT (2003) Giant hemangioma of the liver: MR imaging characteristics in 24 patients. Magn Reson Imaging 21:95–101PubMedCrossRef Danet IM, Semelka RC, Braga L, Armao D, Woosley JT (2003) Giant hemangioma of the liver: MR imaging characteristics in 24 patients. Magn Reson Imaging 21:95–101PubMedCrossRef
36.
go back to reference Valls C, Rene M, Gil M, et al. (1996) Giant cavernous hemangioma of the liver: atypical CT and MR findings. Eur Radiol 6:448–450PubMedCrossRef Valls C, Rene M, Gil M, et al. (1996) Giant cavernous hemangioma of the liver: atypical CT and MR findings. Eur Radiol 6:448–450PubMedCrossRef
37.
go back to reference Coumbaras M, Wendum D, Monnier-Cholley L, et al. (2002) CT and MR imaging features of pathologically proven atypical giant hemangiomas of the liver. AJR Am J Roentgenol 179:1457–1463PubMedCrossRef Coumbaras M, Wendum D, Monnier-Cholley L, et al. (2002) CT and MR imaging features of pathologically proven atypical giant hemangiomas of the liver. AJR Am J Roentgenol 179:1457–1463PubMedCrossRef
38.
go back to reference Vilgrain V, Boulos L, Vullierme MP, et al. (2000) Imaging of atypical hemangiomas of the liver with pathologic correlation. Radiographics 20:379–397PubMedCrossRef Vilgrain V, Boulos L, Vullierme MP, et al. (2000) Imaging of atypical hemangiomas of the liver with pathologic correlation. Radiographics 20:379–397PubMedCrossRef
39.
go back to reference Van Beers B, Roche A, Mathieu D, et al. (1992) Epithelioid hemangioendothelioma of the liver: MR and CT findings. J Comput Assist Tomogr 16:420–424PubMedCrossRef Van Beers B, Roche A, Mathieu D, et al. (1992) Epithelioid hemangioendothelioma of the liver: MR and CT findings. J Comput Assist Tomogr 16:420–424PubMedCrossRef
40.
go back to reference Miller WJ, Dodd GD, Federle MP, Baron RL (1992) Epithelioid hemangioendothelioma of the liver: imaging findings with pathologic correlation. AJR Am J Roentgenol 159:53–57PubMedCrossRef Miller WJ, Dodd GD, Federle MP, Baron RL (1992) Epithelioid hemangioendothelioma of the liver: imaging findings with pathologic correlation. AJR Am J Roentgenol 159:53–57PubMedCrossRef
41.
go back to reference Dong A, Dong H, Wang Y, et al. (2013) MRI and FDG PET/CT findings of hepatic epithelioid hemangioendothelioma. Clin Nucl Med 38:e66–e73PubMedCrossRef Dong A, Dong H, Wang Y, et al. (2013) MRI and FDG PET/CT findings of hepatic epithelioid hemangioendothelioma. Clin Nucl Med 38:e66–e73PubMedCrossRef
42.
go back to reference Bruegel M, Muenzel D, Waldt S, Specht K, Rummeny EJ (2011) Hepatic epithelioid hemangioendothelioma: findings at CT and MRI including preliminary observations at diffusion-weighted echo-planar imaging. Abdom Imaging 36:415–424PubMedCrossRef Bruegel M, Muenzel D, Waldt S, Specht K, Rummeny EJ (2011) Hepatic epithelioid hemangioendothelioma: findings at CT and MRI including preliminary observations at diffusion-weighted echo-planar imaging. Abdom Imaging 36:415–424PubMedCrossRef
43.
go back to reference Rubbia-Brandt L, Giostra E, Brezault C, et al. (2007) Importance of histological tumor response assessment in predicting the outcome in patients with colorectal liver metastases treated with neo-adjuvant chemotherapy followed by liver surgery. Ann Oncol 18:299–304PubMedCrossRef Rubbia-Brandt L, Giostra E, Brezault C, et al. (2007) Importance of histological tumor response assessment in predicting the outcome in patients with colorectal liver metastases treated with neo-adjuvant chemotherapy followed by liver surgery. Ann Oncol 18:299–304PubMedCrossRef
44.
go back to reference Danet IM, Semelka RC, Leonardou P, et al. (2003) Spectrum of MRI appearances of untreated metastases of the liver. AJR Am J Roentgenol 181:809–817PubMedCrossRef Danet IM, Semelka RC, Leonardou P, et al. (2003) Spectrum of MRI appearances of untreated metastases of the liver. AJR Am J Roentgenol 181:809–817PubMedCrossRef
45.
go back to reference Chen W, DelProposto Z, Liu W, et al. (2014) Susceptibility-weighted imaging for the noncontrast evaluation of hepatocellular carcinoma: a prospective study with histopathologic correlation. PLoS ONE 9:e98303PubMedCentralPubMedCrossRef Chen W, DelProposto Z, Liu W, et al. (2014) Susceptibility-weighted imaging for the noncontrast evaluation of hepatocellular carcinoma: a prospective study with histopathologic correlation. PLoS ONE 9:e98303PubMedCentralPubMedCrossRef
46.
go back to reference Forner A, Vilana R, Ayuso C, et al. (2008) Diagnosis of hepatic nodules 20 mm or smaller in cirrhosis: prospective validation of the noninvasive diagnostic criteria for hepatocellular carcinoma. Hepatology 47:97–104PubMedCrossRef Forner A, Vilana R, Ayuso C, et al. (2008) Diagnosis of hepatic nodules 20 mm or smaller in cirrhosis: prospective validation of the noninvasive diagnostic criteria for hepatocellular carcinoma. Hepatology 47:97–104PubMedCrossRef
47.
go back to reference Ronot M, Bahrami S, Calderaro J, et al. (2011) Hepatocellular adenomas: accuracy of magnetic resonance imaging and liver biopsy in subtype classification. Hepatology 53:1182–1191PubMedCrossRef Ronot M, Bahrami S, Calderaro J, et al. (2011) Hepatocellular adenomas: accuracy of magnetic resonance imaging and liver biopsy in subtype classification. Hepatology 53:1182–1191PubMedCrossRef
48.
go back to reference van Aalten SM, Thomeer MG, Terkivatan T, et al. (2011) Hepatocellular adenomas: correlation of MR imaging findings with pathologic subtype classification. Radiology 261:172–181PubMedCrossRef van Aalten SM, Thomeer MG, Terkivatan T, et al. (2011) Hepatocellular adenomas: correlation of MR imaging findings with pathologic subtype classification. Radiology 261:172–181PubMedCrossRef
49.
go back to reference Laumonier H, Bioulac-Sage P, Laurent C, et al. (2008) Hepatocellular adenomas: magnetic resonance imaging features as a function of molecular pathological classification. Hepatology 48:808–818PubMedCrossRef Laumonier H, Bioulac-Sage P, Laurent C, et al. (2008) Hepatocellular adenomas: magnetic resonance imaging features as a function of molecular pathological classification. Hepatology 48:808–818PubMedCrossRef
50.
go back to reference Lewin M, Handra-Luca A, Arrive L, et al. (2006) Liver adenomatosis: classification of MR imaging features and comparison with pathologic findings. Radiology 241:433–440PubMedCrossRef Lewin M, Handra-Luca A, Arrive L, et al. (2006) Liver adenomatosis: classification of MR imaging features and comparison with pathologic findings. Radiology 241:433–440PubMedCrossRef
51.
go back to reference Brancatelli G, Federle MP, Vullierme MP, et al. (2006) CT and MR imaging evaluation of hepatic adenoma. J Comput Assist Tomogr 30:745–750PubMedCrossRef Brancatelli G, Federle MP, Vullierme MP, et al. (2006) CT and MR imaging evaluation of hepatic adenoma. J Comput Assist Tomogr 30:745–750PubMedCrossRef
52.
go back to reference Grazioli L, Morana G, Kirchin MA, Schneider G (2005) Accurate differentiation of focal nodular hyperplasia from hepatic adenoma at gadobenate dimeglumine-enhanced MR imaging: prospective study. Radiology 236:166–177PubMedCrossRef Grazioli L, Morana G, Kirchin MA, Schneider G (2005) Accurate differentiation of focal nodular hyperplasia from hepatic adenoma at gadobenate dimeglumine-enhanced MR imaging: prospective study. Radiology 236:166–177PubMedCrossRef
53.
go back to reference Mahfouz AE, Hamm B, Wolf KJ (1994) Peripheral washout: a sign of malignancy on dynamic gadolinium-enhanced MR images of focal liver lesions. Radiology 190:49–52PubMedCrossRef Mahfouz AE, Hamm B, Wolf KJ (1994) Peripheral washout: a sign of malignancy on dynamic gadolinium-enhanced MR images of focal liver lesions. Radiology 190:49–52PubMedCrossRef
54.
go back to reference Yamamoto M, Ariizumi S, Yoshitoshi K, et al. (2006) Hepatocellular carcinoma with a central scar and a scalloped tumor margin resembling focal nodular hyperplasia in macroscopic appearance. J Surg Oncol 94:587–591PubMedCrossRef Yamamoto M, Ariizumi S, Yoshitoshi K, et al. (2006) Hepatocellular carcinoma with a central scar and a scalloped tumor margin resembling focal nodular hyperplasia in macroscopic appearance. J Surg Oncol 94:587–591PubMedCrossRef
55.
go back to reference Awaya H, Ito K, Honjo K, et al. (1998) Differential diagnosis of hepatic tumors with delayed enhancement at gadolinium-enhanced MRI: a pictorial essay. Clin Imaging 22:180–187PubMedCrossRef Awaya H, Ito K, Honjo K, et al. (1998) Differential diagnosis of hepatic tumors with delayed enhancement at gadolinium-enhanced MRI: a pictorial essay. Clin Imaging 22:180–187PubMedCrossRef
56.
go back to reference Yamashita Y, Fan ZM, Yamamoto H, et al. (1994) Spin-echo and dynamic gadolinium-enhanced FLASH MR imaging of hepatocellular carcinoma: correlation with histopathologic findings. J Magn Reson Imaging 4:83–90PubMedCrossRef Yamashita Y, Fan ZM, Yamamoto H, et al. (1994) Spin-echo and dynamic gadolinium-enhanced FLASH MR imaging of hepatocellular carcinoma: correlation with histopathologic findings. J Magn Reson Imaging 4:83–90PubMedCrossRef
57.
go back to reference Saito K, Kotake F, Ito N, et al. (2005) Gd-EOB-DTPA enhanced MRI for hepatocellular carcinoma: quantitative evaluation of tumor enhancement in hepatobiliary phase. Magn Reson Med Sci 4:1–9PubMedCrossRef Saito K, Kotake F, Ito N, et al. (2005) Gd-EOB-DTPA enhanced MRI for hepatocellular carcinoma: quantitative evaluation of tumor enhancement in hepatobiliary phase. Magn Reson Med Sci 4:1–9PubMedCrossRef
Metadata
Title
Central element in liver masses, helpful, or pitfall?
Authors
C. Rousseau
M. Ronot
E. Sibileau
I. Boulay-Coletta
M. Lewin
V. Duchatelle
V. Vilgrain
M. Zins
Publication date
01-08-2015
Publisher
Springer US
Published in
Abdominal Radiology / Issue 6/2015
Print ISSN: 2366-004X
Electronic ISSN: 2366-0058
DOI
https://doi.org/10.1007/s00261-014-0317-4

Other articles of this Issue 6/2015

Abdominal Radiology 6/2015 Go to the issue

Classics in Abdominal Imaging

The “bear paw” sign

Classics in Abdominal Imaging

The “pancake” adrenal

Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.